Macquarie Group LTD View Ray, Inc. Transaction History

Macquarie Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$3.28 - $4.81 $8,823 - $12,938	-2,690 Reduced 1.19%	222,988 $771,000
Q4 2022 Feb 21, 2023	SELL	$3.65 - $4.82 $256,138 - $338,243	-70,175 Reduced 23.72%	225,678 $1.01 Million
Q3 2022 Nov 14, 2022	SELL	$2.66 - $3.97 $2,492 - $3,719	-937 Reduced 0.32%	295,853 $1.08 Million
Q2 2022 Aug 15, 2022	BUY	$2.42 - $4.05 $7,514 - $12,575	3,105 Added 1.06%	296,790 $786,000
Q1 2022 May 16, 2022	BUY	$3.45 - $5.83 $32,264 - $54,522	9,352 Added 3.29%	293,685 $1.15 Million
Q4 2021 Feb 11, 2022	BUY	$4.89 - $7.59 $1.39 Million - $2.16 Million	284,333 New	284,333 $1.57 Million

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.